Radiopharm Theranostics Limited
RADX
$7.03
-$0.42-5.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.45% | 22.92% | 20.90% | 19.06% | -8.57% |
| Total Depreciation and Amortization | -66.46% | -67.09% | -- | -- | -6.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 237.89% | 231.57% | -142.08% | -143.07% | 233.66% |
| Change in Net Operating Assets | -181.99% | -180.45% | -- | -- | -28.50% |
| Cash from Operations | -25.20% | -22.86% | -88.68% | -93.10% | 1.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -272.87% | -265.87% | -- | -- | 78.75% |
| Cash from Investing | -272.87% | -265.87% | -- | -- | 78.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 35.96% | 35.96% | -- |
| Issuance of Common Stock | -70.45% | -70.45% | 2,068.74% | 2,068.74% | 3,441,375.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 145.34% | 145.34% | -5,356.70% | -5,356.70% | -8,323.33% |
| Cash from Financing | -69.61% | -70.18% | 1,749.29% | 1,792.72% | 147,679.37% |
| Foreign Exchange rate Adjustments | -3,443.18% | -3,368.18% | 4,144.74% | 4,260.53% | -113.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -142.66% | -141.86% | 282.15% | 286.40% | 231.16% |